MA41997A - Combinaisons de cannabinoïdes et de n-acyléthanolamines - Google Patents

Combinaisons de cannabinoïdes et de n-acyléthanolamines

Info

Publication number
MA41997A
MA41997A MA041997A MA41997A MA41997A MA 41997 A MA41997 A MA 41997A MA 041997 A MA041997 A MA 041997A MA 41997 A MA41997 A MA 41997A MA 41997 A MA41997 A MA 41997A
Authority
MA
Morocco
Prior art keywords
acylethanolamines
cannabinoids
combinations
Prior art date
Application number
MA041997A
Other languages
English (en)
Inventor
Ephraim Brener
Elran Haber
Ascher Shmulewitz
Original Assignee
Therapix Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapix Biosciences Ltd filed Critical Therapix Biosciences Ltd
Publication of MA41997A publication Critical patent/MA41997A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
MA041997A 2015-04-29 2016-04-19 Combinaisons de cannabinoïdes et de n-acyléthanolamines MA41997A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562154144P 2015-04-29 2015-04-29

Publications (1)

Publication Number Publication Date
MA41997A true MA41997A (fr) 2021-03-31

Family

ID=57199061

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041997A MA41997A (fr) 2015-04-29 2016-04-19 Combinaisons de cannabinoïdes et de n-acyléthanolamines

Country Status (12)

Country Link
US (7) US11234956B2 (fr)
EP (2) EP4193993A3 (fr)
JP (2) JP6938465B2 (fr)
CN (2) CN116549437A (fr)
AU (3) AU2016254685B2 (fr)
CA (1) CA2984088C (fr)
DK (1) DK3288553T3 (fr)
ES (1) ES2935605T3 (fr)
IL (2) IL291864A (fr)
MA (1) MA41997A (fr)
PL (1) PL3288553T3 (fr)
WO (1) WO2016174661A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019136351A1 (fr) * 2018-01-05 2019-07-11 Altus Labs, Llc Compositions de soins d'hygiène personnelle
WO2019145783A1 (fr) * 2018-01-29 2019-08-01 Therapix Biosciences Ltd. Compositions et méthodes de traitement de l'apnée obstructive du sommeil
EP3773512A4 (fr) * 2018-04-03 2021-12-29 Pure Green, LLC Comprimé ou composition à base d'éthanolamine n-acyle et de cannabinoïde
WO2020160452A1 (fr) * 2019-02-01 2020-08-06 Tess Ventures, Inc. Combinaison de serm, de sarm et de cannabinoïdes destinée à améliorer la sécurité et l'efficacité d'endocrinothérapies
CA3136124C (fr) * 2019-04-15 2024-04-09 Metagenics, Inc. Nouvelle formulation de chanvre et de pois et son utilisation
JP2022530207A (ja) * 2019-04-23 2022-06-28 エスシーアイ スパーク リミティド ４－アミノフェノールの誘導体を増強することのための組成物及び方法
EP3965789A4 (fr) * 2019-05-07 2023-01-25 Ojai Energetics PBC Méthodes de détermination optimisée de dosage de cannabinoïde
EP4017486A4 (fr) * 2019-08-19 2023-09-20 Buzzelet Development And Technologies Ltd Compositions pour le traitement d'un état caractérisé par une déficience en anandamide et leurs utilisations
EP3838346A1 (fr) * 2019-12-20 2021-06-23 Chemo Research SL Capsules de gélatine molle contenant du palmitoyléthanolamide et de l'acide alpha-lipoïque
EP4087554A4 (fr) 2020-01-10 2024-01-17 Pacira Pharmaceuticals, Inc. Traitement de la douleur par administration sous-arachnoïdienne de compositions anesthésiques liposomales à libération prolongée
EP4087568A4 (fr) 2020-01-10 2024-01-17 Pacira Pharmaceuticals, Inc. Traitement de la douleur par administration de compositions anesthésiques liposomales à libération prolongée
US11273122B2 (en) 2020-02-11 2022-03-15 Therese Mainella Combination of cannabis, derivatives thereof and additives in oral care compositions
EP4274573A1 (fr) * 2021-01-11 2023-11-15 Pacira Pharmaceuticals, Inc. Traitement de la douleur de la hanche avec des compositions anesthésiques liposomales à libération prolongée
US20230000936A1 (en) * 2021-06-30 2023-01-05 Demetrix, Inc. Alleviation of itching sensations using cannabinoid compounds
US12036228B2 (en) 2022-04-12 2024-07-16 Shackelford Pharma Inc. Treatment of seizure disorders
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
WO2024124354A1 (fr) * 2022-12-16 2024-06-20 Aima Inc. Compositions et méthodes de traitement ou de prévention de la douleur ou d'autres troubles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060987A2 (fr) * 1998-05-29 1999-12-02 Neurosciences Research Foundation, Inc. Elimination de la douleur au moyen de cannabinoides endogenes
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
GB2394894B (en) * 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
US20090054526A1 (en) 2005-07-14 2009-02-26 Hansen Harald S Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders
GB2432312A (en) * 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
JP5746178B2 (ja) * 2009-09-07 2015-07-08 エピテック・グループ・エス．アール．エル． 超微粉化パルミトイル−エタノールアミドを含む組成物
EP2719375A1 (fr) * 2012-10-10 2014-04-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Cannabinoïdes pour le traitement de cancers liés au mécanisme hedgehog

Also Published As

Publication number Publication date
PL3288553T3 (pl) 2023-03-20
US11234956B2 (en) 2022-02-01
IL291864A (en) 2022-06-01
US20200030281A1 (en) 2020-01-30
JP6938465B2 (ja) 2021-09-22
AU2023251426A1 (en) 2023-11-09
EP4193993A3 (fr) 2023-07-19
AU2021206784B2 (en) 2023-07-20
EP4193993A2 (fr) 2023-06-14
US11207290B2 (en) 2021-12-28
CN107530317A (zh) 2018-01-02
CA2984088C (fr) 2024-04-09
WO2016174661A1 (fr) 2016-11-03
US11197845B2 (en) 2021-12-14
ES2935605T3 (es) 2023-03-08
EP3288553B1 (fr) 2022-12-28
US20180078523A1 (en) 2018-03-22
EP3288553A1 (fr) 2018-03-07
AU2016254685A1 (en) 2017-11-09
US20200022946A1 (en) 2020-01-23
CA2984088A1 (fr) 2016-11-03
CN116549437A (zh) 2023-08-08
AU2021206784A1 (en) 2021-08-12
US20220071949A1 (en) 2022-03-10
US20200038367A1 (en) 2020-02-06
AU2016254685B2 (en) 2021-04-22
IL255238B (en) 2022-05-01
DK3288553T3 (da) 2023-01-23
JP2021107401A (ja) 2021-07-29
JP2018514589A (ja) 2018-06-07
IL255238A0 (en) 2017-12-31
US20210393577A1 (en) 2021-12-23
EP3288553A4 (fr) 2018-12-26
US20220071948A1 (en) 2022-03-10

Similar Documents

Publication Publication Date Title
MA41997A (fr) Combinaisons de cannabinoïdes et de n-acyléthanolamines
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
DK3331876T3 (da) Modulators of ror-gamma
BR112018000129A2 (pt) oxiesteróis e seus métodos de utilização
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
BR112017004648A2 (pt) simuladores mir-29 e os usos deste
BR112016020889A2 (pt) variantes de hppd e métodos de uso
DK3283210T3 (da) Fremgangsmåde
BR112016025413A2 (pt) método de fabricação de um inserto e inserto
DK3132009T3 (da) Fremgangsmåde
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
BR112017018932A2 (pt) etv2 e usos do mesmo
FR3041605B1 (fr) Coupole de rotor, rotor et giravion
ES1137506Y (es) Helice reductora de perdidas
FR3024647B1 (fr) Transat de puericulture
FR3026387B1 (fr) Carenage de rotor, rotor et aeronef
DK3285588T3 (da) Fremgangsmåde
DK3370756T3 (da) Kombination af canrenoat og exenatid
FR3039820B1 (fr) Parachute de palier
FR3019594B1 (fr) Section additionnelle de poussee
BR112018000205A2 (pt) oxiesteróis e métodos de uso destes
UA32480S (uk) Комплект етикеток
FR3023176B3 (fr) Cage de but
ES1147085Y (es) Fotomaton profesional de reducidas dimensiones
UA32407S (uk) Комплект етикеток